Bold Capital Partners is a venture capital firm founded in 2015 and based in Santa Monica, California, with an additional office in Los Altos, California. The firm specializes in early-stage and growth capital investments, focusing primarily on technology companies. Its investment portfolio includes sectors such as life sciences, healthcare, and frontier technology, reflecting a commitment to supporting innovative companies that have the potential for significant impact.
Near Space Labs, headquartered in the United States, is an aerial imagery and earth observation company that provides comprehensive remote sensing solutions for various sectors. The company's services facilitate the monitoring of assets and enable remote access to both broad and specific areas through cloud-based delivery of fully processed images via an API. Near Space Labs supports a range of industries including insurance, utilities, infrastructure, conservation, smart cities, retail, energy, government, and disaster response. By offering affordable and frictionless imaging, the company assists clients in tracking construction progress, addressing issues such as pipeline leaks and vegetation encroachment, and responding to weather-induced damage, thereby providing actionable geospatial information that enhances mobility, leisure, and urban planning.
Chef Robotics
Series A in 2025
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostic tools for both hospital and remote patient monitoring. The company utilizes a proprietary technology called resonance sonomanometry, which employs acoustic stimulation to measure blood pressure continuously and noninvasively, eliminating the need for calibration. By offering round-the-clock monitoring capabilities, Esperto Medical aims to enhance patient care and accessibility, allowing individuals to track their vital signs conveniently from home or within clinical settings.
Feno
Seed Round in 2024
Feno is leading the charge in revolutionizing the oral health industry, recognizing the crucial link between oral health and overall health. Poor oral health has been linked to serious conditions like heart disease, stroke, and diabetes, which is why we are committed to developing innovative solutions that promote better oral health and, ultimately, better overall health. Our cutting-edge products include the 20-second Feno Smartbrush, an at-home oral scanner, and AI powered digital oral health choaches, which leverage the scans to assess and analyze oral health conditions. Our mission is to empower individuals to take control of their oral health to improve their overall health.
Discure
Series A in 2024
Discure Technologies is focused on creating a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). This innovative device employs a novel bioelectric technique that addresses the root cause of DDD, allowing physicians to alleviate pain and restore normal disc function in patients. By promoting healing of the affected discs, Discure seeks to improve the quality of life for individuals suffering from this condition.
Viome Life Sciences
Series D in 2024
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
Openwater
Venture Round in 2024
Openwater is a San Francisco-based startup founded in 2016 that focuses on developing advanced medical technology aimed at diagnosing and treating diseases at the cellular level. The company has created a wearable device that leverages novel optoelectronic technology to offer high-resolution imaging capabilities, effectively replacing traditional MRI methods. By utilizing LCDs with small pixels, Openwater's device generates holographic images that minimize scattering and achieve MRI-like resolution. This innovation enables physicians to diagnose and treat diseases by targeting individual cells while preserving the surrounding tissue, thereby enhancing the precision and effectiveness of medical interventions.
Immunis
Venture Round in 2024
Immunis is a private biotechnology company focused on creating innovative therapies to address immune decline associated with aging and various diseases. The company is developing a stem cell-derived treatment that utilizes human stem cells to generate specific populations of cells. These engineered cells are designed to secrete therapeutic factors that can help restore and modulate the immune system. By harnessing the potential of stem cells, Immunis aims to provide effective solutions for improving immune health and enhancing patient outcomes.
Holoclara
Series A in 2024
Holoclara is an immunotherapy company focused on developing treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief to individuals suffering from these conditions by offering a range of services that include the delivery of therapeutics derived from worm species. These molecules are identified for their potent therapeutic properties and are being developed into safe, orally available treatments. Holoclara’s initiatives are designed to enable patients to lead healthier lives while addressing the challenges posed by autoimmune disorders.
Lucidity
Seed Round in 2024
Lucidity is a multi-cloud storage management platform that optimizes storage solutions across major cloud providers such as AWS, Azure, and Google Cloud. The platform automates the adjustment of block storage in real time, ensuring that enterprises can efficiently allocate resources based on their data requirements without experiencing downtime. By streamlining cloud infrastructure management, Lucidity enables organizations to improve application performance, eliminate infrastructure disruptions, and significantly reduce cloud costs, achieving savings of up to 70%. This approach allows clients to maintain operational continuity while delivering reliable and predictable storage performance.
Synadia
Series B in 2024
Synadia Communications Inc. is a technology company based in Los Angeles, California, focused on developing a global utility platform for connecting digital systems, services, and devices. Established in 2017, Synadia is the leader in the development of NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. The company offers NGS, a secure and globally available communications platform built on NATS.io, along with additional services such as commercial support, consulting, non-recurring engineering, and training. By leveraging its innovative technology, Synadia aims to provide scalable and secure messaging solutions that facilitate modern distributed systems across various applications.
Gallant Therapeutics
Series A in 2024
Gallant Therapeutics is an animal health biotechnology company developing allogeneic, "off-the-shelf" stem cell therapies from their stem cell platform. Gallant is also the leading provider of non-invasive stem cell banking during the spay or neuter process, opening the door to novel regenerative medical treatments formerly unavailable for non-human family members. Clinical studies demonstrate stem cell therapies help pets with a multitude of ailments, including osteoarthritis, atopic dermatitis, chronic kidney disease, and chronic stomatitis, among others. Gallant's first product helps to save cats that would die of chronic gingivostomatitis, with a robust pipeline in development for companion animals.
Mighty Buildings
Series B in 2023
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Viome Life Sciences
Series C in 2023
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
Solarea Bio
Series B in 2023
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.
Colossal Laboratories & Biosciences
Series B in 2023
Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to addressing extinction and biodiversity loss through innovative gene editing technologies, primarily CRISPR. The company focuses on reviving extinct species, such as the woolly mammoth, while also working to protect critically endangered species and restore vital ecosystems. By employing advanced genetic techniques, Colossal aims to create solutions that not only facilitate the repopulation of ecosystems but also contribute to the sustainability of life on Earth. Through its pioneering efforts, Colossal aspires to tackle pressing environmental challenges and support the future of both ecological health and human necessities.
Dreamscape Learn
Series A in 2023
Dreamscape Learn is an edtech company focusing on cinematic story-telling, cutting-edge immersive technologies, and advanced pedagogy. They believe that the best educational designs combine multiple pedagogical modalities. Students study; they apply knowledge and concepts; they learn by doing and do in order to learn; they learn through text, lecture, visual and audio media, hands-on experience, and from one another. They create programs and products that connect all of these modes of engagement.
Syntis Bio
Venture Round in 2023
Syntis Bio is a late-stage preclinical company focused on developing a new class of oral therapies. By utilizing innovative formulations, the company's drugs are designed to target specific tissues, which enhances bioavailability and expands treatment options across a broader range of diseases.
Deciduous Therapeutics
Seed Round in 2022
Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at treating age-related diseases. The company specializes in novel therapeutics that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related health issues. By promoting the clearance of these cells, Deciduous Therapeutics seeks to enhance healthspan and potentially improve the quality of life for individuals experiencing the effects of aging. The company is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, who has founded multiple biotech ventures.
Earth Force
Seed Round in 2022
Earth Force is a company focused on vegetation management, specifically aimed at preventing wildfires in forests and plantations. It has developed a platform that utilizes precision GPS technology and field-based sensors to enhance connectivity and operational efficiency. The system incorporates remote-controlled machines designed for material handling, fire monitoring, and spot-fire suppression. By providing these advanced tools, Earth Force enables clients to effectively protect and manage forest vegetation, contributing to the overall safety and sustainability of forested areas.
Viome Life Sciences
Series C in 2022
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.
KeyCare
Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
AliveCor
Series F in 2022
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Curebase
Series B in 2022
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.
Pyka
Series A in 2022
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft for agricultural and cargo applications. Founded in 2016, the company focuses on creating innovative solutions that enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for precision spraying in agriculture, allowing for effective chemical application over diverse terrains while minimizing environmental impact. The technology incorporates advanced flight controllers and onboard sensors to ensure accuracy and efficiency in operations. Additionally, the aircraft can be utilized for cargo transportation, particularly in remote or challenging areas, showcasing their versatility. Through its commitment to sustainability and technological advancement, Pyka aims to transform traditional practices in crop protection and logistics.
Crowdz
Convertible Note in 2022
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative invoicing software. By automating risk assessment at the receivable level, Crowdz provides funders with valuable insights that facilitate quick decision-making aligned with their investment strategies. The company has auto risk-rated $4.2 billion in receivables, leading to over $93 million in financing through its platform. Its technology bridges real-world assets with decentralized finance by digitizing receivables on-chain, thereby enabling small and midsize enterprises to access essential business financing and enhance their competitive edge. Crowdz has garnered significant support from notable customers and investors, including Citibank, Barclays, and Meta, and has raised over $28 million in funding to date.
Verana Networks
Series B in 2022
Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.
Rugged Robotics
Series A in 2022
Rugged Robotics Inc., founded in 2018 and based in Houston, Texas, specializes in developing robotic platforms tailored for the commercial construction industry. The company’s flagship product, the Mark I, autonomously marks architectural and engineering designs directly onto concrete floors, facilitating accurate construction layout. This robotic system replaces traditional manual methods, which are often slow and prone to errors, thereby enhancing productivity and efficiency on construction sites. Rugged Robotics positions itself as a provider of layout as a service, offering solutions that not only address real-world construction challenges but also save time and reduce costs for contractors. By scaling its fleet and commercializing its technology, Rugged Robotics aims to deliver accessible, hardware-enabled solutions that significantly improve operational workflows in the construction sector.
ParkourSC
Venture Round in 2022
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.
Gameto
Series A in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.
Viome Life Sciences
Series C in 2021
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
MagicCube
Series C in 2021
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.
Meru Health
Series B in 2021
Meru Health, Inc. is a digital healthcare company that focuses on improving the lives of individuals dealing with mental health issues such as depression, anxiety, and stress. Founded in 2015 and based in San Mateo, California, with additional offices in Palo Alto and Helsinki, Meru Health develops a mobile application that connects users to licensed therapists through a structured 12-week program. This program combines continuous remote clinician support with at-home lessons, cognitive behavioral therapy, and coaching on sleep and nutrition. By offering clinically proven and cost-effective digital therapeutic solutions, Meru Health aims to empower patients and enhance the efficiency of mental health treatment.
Elevian
Series A in 2021
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.
Curebase
Series A in 2021
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.
Docbot
Series A in 2021
Docbot, Inc. is an artificial intelligence technology company based in Irvine, California, that specializes in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices, offering a clinical decision support system that aggregates patient information and provides cloud analytics for healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which focuses on real-time image analysis and automated reporting. This platform is designed to detect colorectal cancer and other gastrointestinal conditions by integrating various data sources from imaging systems and pathology requisitions. Docbot aims to enhance patient care and streamline clinical workflows, ultimately reducing cancer risks and improving outcomes for patients in the gastrointestinal specialty.
Chef Robotics
Seed Round in 2021
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
SeQure DX
Venture Round in 2021
SeQure Dx specializes in providing safety data related to CRISPR gene editing therapies, focusing on both on-target and off-target effects. The company develops genomics diagnostic technologies that facilitate target profiling for gene editing, supporting the discovery, clinical development, and diagnostic processes. Its core technologies are designed to identify potential off-target sites prior to the initiation of therapy, ensuring comprehensive confirmation of actual genetic edits. This capability empowers gene editing therapeutics developers, physicians, and patients by enhancing the safety and efficacy of gene editing treatments.
Bionaut Labs
Series A in 2021
Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.
Mighty Buildings
Series B in 2021
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Crowdz
Series A in 2020
Crowdz is a company focused on modernizing the traditional trade finance industry through innovative invoicing software. By automating risk assessment at the receivable level, Crowdz provides funders with valuable insights that facilitate quick decision-making aligned with their investment strategies. The company has auto risk-rated $4.2 billion in receivables, leading to over $93 million in financing through its platform. Its technology bridges real-world assets with decentralized finance by digitizing receivables on-chain, thereby enabling small and midsize enterprises to access essential business financing and enhance their competitive edge. Crowdz has garnered significant support from notable customers and investors, including Citibank, Barclays, and Meta, and has raised over $28 million in funding to date.
Elevian
Venture Round in 2020
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.
AliveCor
Series E in 2020
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Solarea Bio
Series A in 2020
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.
Symbiome
Venture Round in 2020
Symbiome, Inc. is a skincare company based in San Francisco, California, that develops and sells products formulated with microbiomic and plant-based ingredients. Founded in 2017 and originally named Persona Biome, Inc., the company rebranded to Symbiome in December 2019. Its product line emphasizes the use of scientifically proven ancestral ingredients, aiming to replace modern chemicals and provide customers with organic solutions for skin care. By focusing on clarity, vibrance, and resilience, Symbiome offers a natural approach to skincare that meets diverse customer needs.
Deep Longevity
Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on advancing aging and longevity research through the development of aging clocks and biomarkers. Founded in 2016 and based in Hong Kong, the company offers a range of products including the Longevity Cloud, which hosts deep aging clocks, and Young.AI, a web and mobile application designed to assist individuals in monitoring their biological age. Deep Longevity also provides AgeMetric Reports for tracking longevity and employs an AI-based recommendation engine to suggest interventions for improving health outcomes. Its comprehensive approach incorporates various data types such as clinical blood tests, transcriptomic, proteomic, and microbiome information, enabling healthcare providers and aging centers to predict biological age with greater accuracy and support preventative medicine initiatives.
Proprio
Series A in 2020
Proprio, Inc. is a Seattle-based company that develops advanced surgical technology aimed at enhancing surgical accuracy, simplifying workflows, and improving patient outcomes. Founded in 2016, Proprio utilizes machine learning, artificial intelligence, and mixed-reality user interfaces to create a next-generation surgical navigation and imaging platform. This innovative system replaces traditional surgical microscopes, loupes, and navigation systems by offering networked camera arrays and depth-sensing technology, allowing users to navigate live 3D environments with depth perception from any angle. Proprio's goal extends beyond merely replacing existing technologies; it seeks to advance medicine by integrating the latest digital innovations, moving away from outdated practices and focusing on software and data to improve surgical practices and outcomes.
MagicCube
Series B in 2020
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.
Gali Health
Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.
Meru Health
Series A in 2020
Meru Health, Inc. is a digital healthcare company that focuses on improving the lives of individuals dealing with mental health issues such as depression, anxiety, and stress. Founded in 2015 and based in San Mateo, California, with additional offices in Palo Alto and Helsinki, Meru Health develops a mobile application that connects users to licensed therapists through a structured 12-week program. This program combines continuous remote clinician support with at-home lessons, cognitive behavioral therapy, and coaching on sleep and nutrition. By offering clinically proven and cost-effective digital therapeutic solutions, Meru Health aims to empower patients and enhance the efficiency of mental health treatment.
Chef Robotics
Seed Round in 2020
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
Pyka
Seed Round in 2019
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft for agricultural and cargo applications. Founded in 2016, the company focuses on creating innovative solutions that enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for precision spraying in agriculture, allowing for effective chemical application over diverse terrains while minimizing environmental impact. The technology incorporates advanced flight controllers and onboard sensors to ensure accuracy and efficiency in operations. Additionally, the aircraft can be utilized for cargo transportation, particularly in remote or challenging areas, showcasing their versatility. Through its commitment to sustainability and technological advancement, Pyka aims to transform traditional practices in crop protection and logistics.
GuRu
Series A in 2019
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.
Metawave
Series A in 2019
Metawave Corporation, founded in 2017 and based in Palo Alto, California, specializes in developing advanced beamsteering radars that utilize metamaterials and artificial intelligence for the automotive industry. The company focuses on enhancing safety and connectivity in autonomous driving through its flagship radar platform, SPEKTRA, which enables 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that help direct signals in areas with limited connectivity. The company is also advancing wireless communications by creating smart beamsteering antennas designed for 4G and 5G networks, aiming to support faster connectivity for a wide range of users. Metawave's innovative technology originated from research at Xerox PARC, reflecting its commitment to revolutionizing the future of transportation and communications.
Insilico Medicine
Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
ParkourSC
Series B in 2019
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.
Mighty Buildings
Series A in 2019
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Gallant Pet
Series A in 2019
Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for dogs. Founded in 2018, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for dogs suffering from osteoarthritis and other musculoskeletal issues. In addition to its preservation services, the company is engaged in clinical research to develop effective stem cell therapies for various conditions. Through its innovative approach, Gallant Pet enables pet owners to preserve their pets' young stem cells for future medical treatments.
Gali Health
Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, established in 2015. The company focuses on developing a mobile application named Gali, which serves as a personal health assistant designed to support individuals with chronic conditions. By leveraging collective intelligence, Gali enables users to proactively manage their health through crowdsourced personal health data and medically-validated insights. The application employs artificial intelligence to provide highly personalized support, addressing medical, lifestyle, and psychological aspects of living with chronic diseases. Gali Health aims to empower users by ensuring they do not feel isolated or powerless in managing their health, advancing consumer-driven healthcare through innovative technology and personalized health tracking.
Viome Life Sciences
Series B in 2019
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
Mojo Vision
Series B in 2019
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Docbot
Seed Round in 2019
Docbot, Inc. is an artificial intelligence technology company based in Irvine, California, that specializes in gastrointestinal diseases. The company develops web-based applications for iOS and Android devices, offering a clinical decision support system that aggregates patient information and provides cloud analytics for healthcare professionals. Its flagship product is built on the UltivisionAI software platform, which focuses on real-time image analysis and automated reporting. This platform is designed to detect colorectal cancer and other gastrointestinal conditions by integrating various data sources from imaging systems and pathology requisitions. Docbot aims to enhance patient care and streamline clinical workflows, ultimately reducing cancer risks and improving outcomes for patients in the gastrointestinal specialty.
Iota Biosciences
Series A in 2018
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. It specializes in the development of wireless sensors and devices aimed at monitoring, measuring, and stimulating internal nerves, muscles, and organs for electroceutical applications, particularly in the treatment of immune and neural disorders. The company has pioneered neural dust technology, utilizing implantable, mote-sized ultrasonic sensors that enable untethered and real-time wireless cortical recordings, improving the methods by which physicians monitor and treat various diseases. Iota's mission is to create safe and effective bioelectronic devices that transform disease management and enhance patient care. As a subsidiary of Astellas Pharma, Iota is committed to leveraging innovative science and technology to advance the field of bioelectronics and make a meaningful impact on patients' lives.
Octi
Seed Round in 2018
Octi is the world’s first augmented reality social platform where reality merges with the metaverse and empowers anyone to create vibrant content with digital objects and scenes, rewarding creators with virtual and physical goods from leading brands. Octi’s independent Los Angeles-based team builds and combines the latest in machine learning, computer vision, and AR technologies to deliver the killer applications of the future.
Insilico Medicine
Series A in 2018
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Oura
Series A in 2018
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
IVIVA
Seed Round in 2018
IVIVA Medical focuses on developing autologous tissue constructs to address end-stage renal disease (ESRD), a condition affecting over 500,000 patients in the United States. As transplant remains the only definitive treatment for ESRD, the majority of patients do not receive donor kidneys. The company utilizes advanced technologies in tissue engineering, 3D additive manufacturing, and stem cell biology to create bioartificial platforms that not only provide therapeutic solutions but also lay the groundwork for future engineered functional tissues. Through these innovations, IVIVA aims to contribute to the field of regenerative medicine and help alleviate the shortage of donor organs.
Synadia
Seed Round in 2018
Synadia Communications Inc. is a technology company based in Los Angeles, California, focused on developing a global utility platform for connecting digital systems, services, and devices. Established in 2017, Synadia is the leader in the development of NATS.io, an open-source messaging system designed for cloud-native applications, microservices architectures, and Internet of Things (IoT) messaging. The company offers NGS, a secure and globally available communications platform built on NATS.io, along with additional services such as commercial support, consulting, non-recurring engineering, and training. By leveraging its innovative technology, Synadia aims to provide scalable and secure messaging solutions that facilitate modern distributed systems across various applications.
Elevian
Convertible Note in 2018
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company focuses on developing medicines that aim to restore regenerative capacity and address age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating blood factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscle. Its therapeutics are designed to target the underlying mechanisms of aging, with applications in stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. Through its innovative approach, Elevian seeks to prevent and treat the effects of aging by enhancing the body's natural repair and regeneration processes.
Exo
Series A in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.
Atomiton
Seed Round in 2017
Atomiton is a developer of industrial software that aims to transform and optimize operations across various industries. The company's platform utilizes artificial intelligence and machine learning to enhance operational efficiencies and perform real-time industrial analytics. By providing insights into carbon emissions and energy consumption, Atomiton enables businesses to track sustainability metrics, which helps in reducing costs and minimizing energy, water, and carbon intensity. This focus on sustainability not only aids organizations in achieving operational excellence but also supports their efforts to lower their environmental impact.
Dreamscape Immersive
Series B in 2017
Dreamscape Immersive, Inc. specializes in location-based virtual reality entertainment, offering innovative experiences that blend cinematic storytelling with the excitement of theme parks. Founded in 2016 and headquartered in Culver City, California, the company has developed a platform called Dreamscape, designed to deliver immersive narratives that can be enjoyed with family and friends. With locations in Los Angeles, Dallas, Columbus, and Dubai, Dreamscape provides audiences with access to both original content and franchised experiences, catering to a diverse range of VR enthusiasts. The company's approach aims to redefine mainstream entertainment by creating engaging and interactive environments.
ParkourSC
Series A in 2017
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.
GuRu
Seed Round in 2017
GuRu Wireless, Inc. enables safe, effective and customizable transmission of power over-the-air using proprietary millimeter-wave (mmWave) integrated circuits, modules and proprietary Smart RF Lensing technology. A miniature-sized power transfer system delivers power at an unprecedented distance efficiently and with precision. GuRu's wireless solution can be used as a charging hub or a power source in many settings where access to an energy source is needed. It is easy to install, safe, and sophisticated enough to find and adjust for various power levels to sync with the needs of any device. Even during use, it continuously charges devices and as a safety measure, reroutes power as necessary. Founded in 2017 by a team of scientists and engineers from Caltech, GuRu aims to ensure access to power be as ubiquitous as WiFi.
Metawave
Seed Round in 2017
Metawave Corporation, founded in 2017 and based in Palo Alto, California, specializes in developing advanced beamsteering radars that utilize metamaterials and artificial intelligence for the automotive industry. The company focuses on enhancing safety and connectivity in autonomous driving through its flagship radar platform, SPEKTRA, which enables 3D imaging and vehicle-to-vehicle communications. Additionally, Metawave offers TURBO active repeaters to improve signal coverage in challenging environments and ECHO passive reflectors that help direct signals in areas with limited connectivity. The company is also advancing wireless communications by creating smart beamsteering antennas designed for 4G and 5G networks, aiming to support faster connectivity for a wide range of users. Metawave's innovative technology originated from research at Xerox PARC, reflecting its commitment to revolutionizing the future of transportation and communications.
Pyka
Pre Seed Round in 2017
Pyka, Inc. is a startup based in Oakland, California, that specializes in the development of autonomous electric aircraft for agricultural and cargo applications. Founded in 2016, the company focuses on creating innovative solutions that enhance safety, affordability, and accessibility in aviation. Pyka's aircraft are designed for precision spraying in agriculture, allowing for effective chemical application over diverse terrains while minimizing environmental impact. The technology incorporates advanced flight controllers and onboard sensors to ensure accuracy and efficiency in operations. Additionally, the aircraft can be utilized for cargo transportation, particularly in remote or challenging areas, showcasing their versatility. Through its commitment to sustainability and technological advancement, Pyka aims to transform traditional practices in crop protection and logistics.
MagicCube
Series A in 2017
MagicCube is a developer of a security platform that focuses on protecting digital transactions against various threats, including on-device, cloud, and network attacks. Its technology, based on a software TEE (Trusted Execution Environment), allows for the secure management and deployment of IoT and mobile solutions on a large scale. Unlike traditional hardware-based security tools, MagicCube's platform offers a comparable level of protection without the associated complexities and costs, making it easier for businesses to safeguard their operations. This innovative approach helps to prevent significant security issues such as cloning, lifting, spoofing, and tampering, thereby enhancing the overall security posture of its clients.
Viome Life Sciences
Series A in 2017
Viome, Inc. is a biotechnology company based in Bellevue, Washington, founded in 2016 by Naveen Jain. It specializes in providing wellness monitoring kits that analyze biological samples, including blood, urine, saliva, and stool, to create comprehensive health profiles. Utilizing advanced testing technology, Viome examines RNA from stool samples to identify the various microbial communities within the digestive system, including bacteria, viruses, and fungi. The insights generated from these analyses enable users to receive personalized recommendations for diet and lifestyle adjustments aimed at improving their overall health. Viome's products are available for purchase through distributors and online platforms, allowing individuals to monitor and enhance their microbiome health, mitochondrial health, and cellular health effectively.
Exo
Venture Round in 2017
Exo is a medical device startup focused on developing a handheld ultrasound platform for imaging and therapeutic applications. The company aims to provide affordable and user-friendly medical imaging solutions for healthcare professionals globally. By integrating advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost efficiencies of semiconductor manufacturing, Exo significantly lowers the costs associated with medical imaging. This technology allows healthcare providers to make vital, real-time decisions that enhance patient outcomes. Exo's commitment to high-quality, accessible imaging represents a significant advancement in medical technology, making effective diagnostic tools available at an unprecedented price point.
Dreamscape Immersive
Series A in 2017
Dreamscape Immersive, Inc. specializes in location-based virtual reality entertainment, offering innovative experiences that blend cinematic storytelling with the excitement of theme parks. Founded in 2016 and headquartered in Culver City, California, the company has developed a platform called Dreamscape, designed to deliver immersive narratives that can be enjoyed with family and friends. With locations in Los Angeles, Dallas, Columbus, and Dubai, Dreamscape provides audiences with access to both original content and franchised experiences, catering to a diverse range of VR enthusiasts. The company's approach aims to redefine mainstream entertainment by creating engaging and interactive environments.
DigiLens
Series B in 2017
DigiLens Inc. is a developer and manufacturer of optical platform and photopolymer technology solutions specializing in waveguide displays for extended reality (XR) applications. The company offers a range of products, including the Crystal30 and Crystal50 lenses, which enable original equipment manufacturers (OEMs) to create customizable XR devices for both enterprise and consumer markets. DigiLens also provides innovative solutions like the DigiLens AutoHUD, which enhances the field of view and reduces component size in heads-up displays, and CrystalClear, an augmented reality heads-up display. In addition to display technologies, DigiLens supplies light engines and hardware development kits, such as Insight30, which assist users in evaluating and developing wearable devices. Founded in 1997 and based in Sunnyvale, California, DigiLens has positioned itself as a leader in holographic waveguide technology, enabling various industries, including automotive, enterprise, consumer, avionics, and military, to leverage XR capabilities.
Terramera
Venture Round in 2016
Terramera, Inc. is a Vancouver-based company that develops and manufactures plant-based pesticides and fertilizers. Founded in 2009, it focuses on providing alternatives to conventional chemical products in agriculture. The company's offerings include Proof, a solution for bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera integrates artificial intelligence with scientific principles and nature to create innovative agriculture technology platforms. Its mission is to transform food production while ensuring a healthy, safe environment free from toxic chemicals, ultimately supporting sustainable and organic farming practices that enhance yields and profitability for farmers and growers.
Epharmix
Seed Round in 2016
Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools for the healthcare industry. Founded in 2015 and based in Saint Louis, Missouri, Epharmix provides digital interventions designed to enhance patient-physician engagement, automate the collection of clinical data, and alert healthcare providers for effective chronic care management. Its products aim to improve care for underserved patients while also reducing the workload of care teams, ultimately enhancing patient engagement and health outcomes.
Meta View
Series B in 2016
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.
Terramera
Venture Round in 2016
Terramera, Inc. is a Vancouver-based company that develops and manufactures plant-based pesticides and fertilizers. Founded in 2009, it focuses on providing alternatives to conventional chemical products in agriculture. The company's offerings include Proof, a solution for bed bugs and dust mites; Actigate, an organic pesticide; and Rango, a pest control and crop protection product. Terramera integrates artificial intelligence with scientific principles and nature to create innovative agriculture technology platforms. Its mission is to transform food production while ensuring a healthy, safe environment free from toxic chemicals, ultimately supporting sustainable and organic farming practices that enhance yields and profitability for farmers and growers.
Singularity University
Series A in 2016
Singularity University, officially known as Singularity Education Group, is a benefit corporation based in Santa Clara, California, founded in 2008. It operates as a learning and innovation community that collaborates with entrepreneurs, corporations, nonprofits, governments, investors, and academic institutions. The organization provides a range of educational programs, including executive and exponential innovation programs, an incubator, and a global startup program. Its offerings encompass online courses focused on exponential thinking and behavioral transformation, as well as international summits and events aimed at fostering collaboration and innovation. Singularity University aims to equip individuals and organizations with the knowledge and tools to leverage advanced technologies such as artificial intelligence, robotics, and biotechnology to address significant global challenges like education, health, and environmental sustainability. Through its global network, which includes numerous chapters and alumni, Singularity University seeks to inspire and empower individuals to create impactful solutions that benefit humanity.
BlueDot
Series A in 2016
BlueDot focuses on harnessing innovative technologies from NASA and national laboratories to address significant global challenges. By identifying groundbreaking scientific advancements, the company aims to collaborate with skilled entrepreneurs to transform these innovations into viable businesses. One of BlueDot's key projects involves the development of diagnostic devices that help prevent the misuse of antibiotics. These devices are designed to quickly differentiate between bacterial and viral infections in patients exhibiting cold symptoms, allowing healthcare professionals to prescribe the appropriate treatment promptly. This approach not only enhances patient care but also contributes to broader public health efforts by reducing the overuse of antibiotics.
BlueLine Grid
Venture Round in 2016
BlueLine Grid, Inc. is a provider of mobile solutions that connects law enforcement, emergency services, security teams, and government agencies across the United States. Founded in 2013 and headquartered in Annapolis, Maryland, the company offers an encrypted suite of tools designed for secure communication and collaboration. These tools include messaging, voice, location services, conferencing, and file-sharing capabilities, tailored to meet the needs of public and private security officials. One of their key offerings is GridTeam, a mobile application that enables users to connect based on area, organization, proximity, or specialty. Additionally, the company provides a Grid bot for Microsoft Skype, allowing users to engage in mass notifications and group conference calls seamlessly. BlueLine Grid aims to enhance communication and operational efficiency for its clients while ensuring privacy and compliance.
CloudMondo
Venture Round in 2016
CloudMondo is a technology startup located in Silicon Valley, specializing in an online marketplace for Over-The-Top (OTT) network services. The company has developed a cloud-based platform designed to enhance global internet connectivity, viewing access to the internet as a fundamental human right. This innovative platform utilizes artificial intelligence, open-source technology, virtualization, and software-defined networking to provide affordable and interactive broadband solutions. By addressing the cost and complexity barriers associated with connectivity, CloudMondo aims to deliver highly accessible broadband services. The company also offers a suite of OTT services that enable various entities, including municipalities, service providers, and businesses, to generate revenue while providing interactive access to their users. Currently, CloudMondo's solutions are operational in 12 countries across four continents, reflecting its commitment to enhancing digital connectivity worldwide.
Kindred AI
Series A in 2015
Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platform that integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.
Meta View
Series A in 2015
Meta View is a technology company specializing in augmented and virtual reality solutions, catering to various industries such as manufacturing, communication, media, medicine, education, and 3D modeling. Founded in 2019 by Ben Sand, Meron Gribetz, and Raymond Lo, the company develops wearable devices and development kits, including the Meta 1 and Meta 2, which enable users to interact with holograms and access digital information seamlessly. Headquartered in San Mateo, California, Meta View distributes its products to markets in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Singapore, Taiwan, and throughout the European Union and EFTA. The company's innovative offerings leverage machine learning and artificial intelligence to enhance user experiences in both augmented and virtual reality environments.
ParkourSC
Seed Round in 2014
ParkourSC is a logistics and supply chain company founded in 2014 and headquartered in Milpitas, California. The company focuses on digital transformation within the manufacturing and pharmaceutical sectors by offering a cloud-based sensor platform. This platform creates a digital twin of the supply chain, processing billions of events per second to provide real-time diagnostic and predictive insights regarding asset location, condition, utilization, and anomaly detection. By collecting data from various sources, ParkourSC enables continuous visibility into the context and timing of materials and assets, allowing businesses to proactively predict disruptions and enhance operational efficiency.
AliveCor
Series B in 2012
AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.